返回成功案例
医疗健康 | 科技、媒体及通讯

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Founded in 1989, Medis Medical Imaging Systems B.V. provides high-quality quantitative analysis solutions for cardiovascular imaging to the medical community. Medis’ software is internationally appreciated due to its ease of use and clinical outcomes for patients. The company continuously focuses on creating, researching and innovating towards clinically relevant software solutions in the field of cardiovascular imaging.

Oaklins’ team in the Netherlands acted as the exclusive strategic advisor to the shareholders and management of Medis Medical Imaging Systems B.V.

“We are delighted to be taking this next step with GE HealthCare, a fellow leader in the interventional cardiology domain. Building on Medis QFR’s decade of AI research, customer-focused product development, clinical evidence generation and business development, we are excited to be able to further accelerate our efforts around Medis QFR to enable more hospitals and clinicians to apply physiology in day-to-day interventional practice as part of clinical care best practices, making this technology more accessible and available to patients than ever before.”

Maya Barley

CEO, Medis Medical Imaging Systems B.V.

联系交易团队

Martijn de Win

总监
阿姆斯特丹, 荷兰
Oaklins Netherlands

Robert Boersma

合伙人
阿姆斯特丹, 荷兰
Oaklins Netherlands

Robbert Bon

高级经理
阿姆斯特丹, 荷兰
Oaklins Netherlands

Baran Temur

高级经理
阿姆斯特丹, 荷兰
Oaklins Netherlands

相关交易

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
医疗健康

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth, as well as investing in service quality, innovation and efficiency.

更多信息
Scholarcy Limited has been acquired by Texthelp Group
科技、媒体及通讯

Scholarcy Limited has been acquired by Texthelp Group

Texthelp Group, a global provider of digital tools for inclusive learning and working, has acquired Scholarcy Limited. This acquisition marks a significant step towards fulfilling Texthelp’s vision of improving the literacy and understanding of one billion people by 2030.

更多信息
HD Clinical Ltd. has been acquired by NEXUS AG
医疗健康 | 科技、媒体及通讯

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

更多信息